跳至主要内容
临床试验/CTRI/2018/03/012413
CTRI/2018/03/012413招募中未知

Comparative efficacy of Sitagliptin and Teneligliptin as add on therapy to Metformin in type 2 diabetes mellitus patients.

Department of Pharmacology and Therapeutics0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with 18-70 years of age.
  • 2. Newly diagnosed patients with Type-2 Diabetes Mellitus.
  • a. Patients with an HBA1c value above or equal to 6.5 percent. OR
  • b. Patients with fasting glucose above or equal to 126 mg/dl.OR
  • c. Patients with 2-hour glucose, following ingestion of 75 g glucose load, above or equal to 200 mg. OR
  • d. Symptomatic patients with random plasma glucose above or equal to 200 mg.

排除标准

  • 1. Patients with Type - 1 Diabetes Mellitus
  • 2. Patients with a history of severe diabetic complications: Ketoacidosis, Retinopathy, Nephropathy, Neuropathy.
  • 3. Hypersensitivity to any of the used drugs.
  • 4. Pregnant and lactating females
  • 5. Liver and kidney dysfunction or severe anemia
  • 6. Patients with serious cardiovascular disease (NYHA class I-IV CHF or history of MI or stroke) or cerebrovascular conditions within 6 months before enrolment.

研究者

发起方
Department of Pharmacology and Therapeutics

相似试验